Net profit of Caplin Point Laboratories rose 13.87% to Rs 130.80 crore in the quarter ended September 2024 as against Rs 114.87 crore during the previous quarter ended September 2023. Sales rose 17.81% to Rs 483.10 crore in the quarter ended September 2024 as against Rs 410.06 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
Sales | 483.10 | 410.06 | 18 |
OPM % | 34.08 | 33.51 | - |
PBDT | 185.22 | 157.76 | 17 |
PBT | 168.46 | 146.00 | 15 |
NP | 130.80 | 114.87 | 14 |